Catalyst Wire Dossier Catalyst Wire Dossier

AIN457 regimen

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AIN457 regimen, covering 2017-12-05 to 2017-12-05. Get the full timeline:

Most recent: Clinical Trial Update: AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis [Phase 2]

See pricing